Emerging information from different
basic and clinical arenas has centered attention on the crucial role of insulin during stress and in particular in the acutely ill patient.
Elegant clinical studies indicate that aggressive glucose control reduces mortality, while the role of insulin, independent of glucose control,
is also being evaluated. The purpose of this meeting is to review the most currently relevant information assessing insulin therapy in the
acutely ill as well as to explore the potential underlying mechanisms involved in these processes.
Sponsors
National
Institute of Diabetes and Digestive and Kidney Diseases
American
Association of Clinical Endocrinologists
American
Diabetes Association
The
Endocrine Society
Society of Critical Care Medicine
|